During the past decade, Hopital Yalgado Ouedraogo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Yalgado Ouedraogo" #1 collaborator was "Gustave Roussy, Cancer Campus, Grand Paris" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Yalgado Ouedraogo" are "Burkitt Lymphoma" (1 trials), "Pediatric Cancer" (1 trials) and "Retinoblastoma" (1 trials). Many other conditions were trialed in "Hopital Yalgado Ouedraogo" in a lesser frequency.

Most popular intervention types in "Hopital Yalgado Ouedraogo" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "OBSERVATIONAL" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Yalgado Ouedraogo" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Yalgado Ouedraogo". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hopital Yalgado Ouedraogo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Yalgado Ouedraogo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".